Table 2.
Demographic and Clinical Predictors of CVLT-C and VAL (N = 71)
Variable | Subgroup | N | Baseline Intercept |
Change per month | Estimated 5 year score | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
SE | p-value | Slope | SE | p-value | Score | SE | p-value | ||||
California Verbal Learning Test — Children’s Version (CVLT-C) | |||||||||||
Age at CRT | ≥ 5 years | 34 | 45.56 | 2.00 | ns | .154 | .051 | <.01 | 54.79 | 2.38 | .01 |
< 5 years | 37 | 43.50 | 2.46 | ns | .025 | .075 | ns | 44.97 | 3.06 | ns | |
Diagnosis to CRT | ≥ 2 months | 33 | 43.12 | 2.28 | ns | .067 | .064 | ns | 47.13 | 2.85 | ns |
< 2 months | 38 | 44.77 | 2.05 | ns | .148 | .058 | .01 | 53.65 | 2.65 | ns | |
Gender | Female | 35 | 44.83 | 2.25 | ns | .116 | .065 | ns | 51.82 | 2.87 | ns |
Male | 36 | 43.26 | 2.08 | ns | .100 | .060 | ns | 49.25 | 2.82 | ns | |
Tumor Location | Infratentorial | 52 | 45.50 | 1.76 | ns | .067 | .050 | ns | 49.53 | 2.33 | ns |
Supratentorial | 19 | 40.74 | 2.73 | ns | .203 | .080 | .01 | 52.92 | 3.88 | ns | |
Number of Surgeries | 1 | 44 | 46.41 | 1.81 | .04 | .071 | .053 | ns | 50.68 | 2.51 | ns |
≥ 2 | 27 | 40.35 | 2.36 | ns | .159 | .069 | .02 | 49.86 | 3.31 | ns | |
Hydrocephalus | No | 23 | 41.64 | 2.60 | ns | .178 | .075 | .02 | 52.34 | 3.49 | ns |
Yes | 48 | 45.31 | 1.88 | ns | .072 | .054 | ns | 49.65 | 2.47 | ns | |
Shunt | No | 49 | 44.88 | 1.79 | ns | .124 | .052 | .01 | 52.31 | 2.41 | ns |
Yes | 22 | 42.03 | 2.83 | ns | .083 | .079 | ns | 47.02 | 3.51 | ns | |
Pre CRT Chemotherapy | No | 56 | 44.99 | 1.66 | ns | .093 | .048 | .05 | 50.60 | 2.24 | ns |
Yes | 15 | 40.12 | 3.49 | ns | .180 | .109 | ns | 50.93 | 4.88 | ns | |
Visual Auditory Learning (VAL) | |||||||||||
Age at CRT | ≥ 5 years | 34 | 97.93 | 3.29 | ns | .178 | .065 | <.01 | 108.58 | 3.32 | ns |
< 5 years | 37 | 89.18 | 3.77 | ns | .176 | .099 | ns | 99.74 | 4.22 | ns | |
Diagnosis to CRT | ≥ 2 months | 33 | 88.58 | 3.62 | ns | .190 | .081 | .02 | 99.95 | 3.81 | ns |
< 2 months | 38 | 97.49 | 3.29 | ns | .175 | .074 | .02 | 108.00 | 3.55 | ns | |
Gender | Female | 35 | 92.27 | 3.60 | ns | .149 | .080 | ns | 101.20 | 3.74 | ns |
Male | 36 | 94.61 | 3.42 | ns | .208 | .073 | <.01 | 107.10 | 3.66 | ns | |
Tumor Location | Infratentorial | 52 | 94.94 | 2.91 | ns | .160 | .064 | .01 | 104.52 | 3.09 | ns |
Supratentorial | 19 | 89.56 | 4.64 | ns | .223 | .103 | .03 | 102.93 | 5.14 | ns | |
Number of Surgeries | 1 | 44 | 97.86 | 3.02 | .02 | .147 | .068 | .03 | 106.68 | 3.26 | ns |
≥ 2 | 27 | 86.21 | 3.91 | ns | .226 | .089 | .01 | 99.79 | 4.27 | ns | |
Hydrocephalus | No | 23 | 97.08 | 4.28 | ns | .208 | .094 | .02 | 109.59 | 4.51 | ns |
Yes | 48 | 91.54 | 3.04 | ns | .169 | .068 | .01 | 101.67 | 3.20 | ns | |
Shunt | No | 49 | 97.47 | 2.80 | .01 | .148 | .063 | .02 | 106.37 | 3.13 | ns |
Yes | 22 | 84.46 | 4.32 | ns | .244 | .095 | .01 | 99.13 | 4.54 | ns | |
Pre CRT Chemotherapy | No | 56 | 94.04 | 2.78 | ns | .212 | .058 | <.01 | 106.75 | 2.76 | .05 |
Yes | 15 | 91.40 | 5.64 | ns | .037 | .134 | ns | 93.62 | 6.01 | ns |
CRT = conformal radiation therapy; ns = not significant